Literature DB >> 28642747

Propionibacterium freudenreichii Surface Protein SlpB Is Involved in Adhesion to Intestinal HT-29 Cells.

Fillipe L R do Carmo1,2, Houem Rabah2,3, Song Huang2,4, Floriane Gaucher2, Martine Deplanche2, Stéphanie Dutertre5, Julien Jardin2, Yves Le Loir2, Vasco Azevedo1, Gwénaël Jan2.   

Abstract

Propionibacterium freudenreichii is a beneficial bacterium traditionally used as a cheese ripening starter and more recently for its probiotic abilities based on the release of beneficial metabolites. In addition to these metabolites (short-chain fatty acids, vitamins, and bifidogenic factor), P. freudenreichii revealed an immunomodulatory effect confirmed in vivo by the ability to protect mice from induced acute colitis. This effect is, however, highly strain-dependent. Local action of metabolites and of immunomodulatory molecules is favored by the ability of probiotics to adhere to the host cells. This property depends on key surface compounds, still poorly characterized in propionibacteria. In the present study, we showed different adhesion rates to cultured human intestinal cells, among strains of P. freudenreichii. The most adhesive one was P. freudenreichii CIRM-BIA 129, which is known to expose surface-layer proteins. We evidenced here the involvement of these proteins in adhesion to cultured human colon cells. We then aimed at deciphering the mechanisms involved in adhesion. Adhesion was inhibited by antibodies raised against SlpB, one of the surface-layer proteins in P. freudenreichii CIRM-BIA 129. Inactivation of the corresponding gene suppressed adhesion, further evidencing the key role of slpB product in cell adhesion. This work confirms the various functions fulfilled by surface-layer proteins, including probiotic/host interactions. It opens new perspectives for the understanding of probiotic determinants in propionibacteria, and for the selection of the most efficient strains within the P. freudenreichii species.

Entities:  

Keywords:  SlpB; adhesion; immunomodulation; probiotic; surface proteins

Year:  2017        PMID: 28642747      PMCID: PMC5462946          DOI: 10.3389/fmicb.2017.01033

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


Introduction

Propionibacterium freudenreichii is a GRAS (Generally Recognized As Safe) actinobacterium consumed in high amounts in fermented dairy products. It is a beneficial bacterium used in the food industry for the production of vitamins, for cheese ripening, and for its probiotic properties (Cousin et al., 2010). Probiotics are defined as “living microorganisms which when administered in adequate amounts confer a health benefit on the host” (Food and Agriculture Organization of the United Nations and World Health Organization, 2002). P. freudenreichii indeed revealed probiotic traits including modulation of intestinal inflammation (Mitsuyama et al., 2007; Foligné et al., 2010, 2013), as well as properties linked to the production of beneficial metabolites such as short-chain fatty acids (Jan et al., 2002; Lan et al., 2007; Cousin et al., 2012b), vitamins and the bifidogenic compound 1,4-dihydroxy-2-naphthoic acid (DHNA) (Bouglé et al., 1999; Kaneko, 1999; Hojo et al., 2002; Ouwehand et al., 2002; Seki et al., 2004; Mitsuyama et al., 2007). Microorganisms that live in or transit through the digestive tract of humans may establish a symbiotic relationship with the host, thus promoting intestinal homeostasis (de Souza and Fiocchi, 2016). Consumption of P. freudenreichii selected strains can enhance human complex intestinal microbiota through the increase of other beneficial bacteria populations, such as bifidobacteria (Bouglé et al., 1999; Kaneko, 1999; Hojo et al., 2002; Ouwehand et al., 2002; Seki et al., 2004; Mitsuyama et al., 2007). In contrast, out of normal physiological conditions, the digestive microbiota may be involved in a variety of immune and inflammatory disorders (Vitetta et al., 2014). One example is inflammatory bowel diseases (IBD), chronic inflammatory disorders that severely affect the digestive tract and may lead, in the long term, to the irreversible deterioration of their structure and function (Belkaid and Hand, 2014; Vitetta et al., 2015). Cheese containing P. freudenreichii, in conjunction with Lactobacillus delbrueckii (Plé et al., 2016) or as a single strain (Plé et al., 2015), was recently shown to exert immunomodulatory effects, to protect mice against TNBS-induced colitis, to alleviate the severity of symptoms and to modulate local and systemic inflammation markers. Such cheese is currently tested in a pilot clinical trial (ClinicalTrials.gov, 2017). Interestingly, removal of propionibacteria surface-layer (S-layer) proteins, which are non-covalently anchored to the cell surface via an S-layer homology (SLH) domain, suppressed the induction of anti-inflammatory cytokines (Foligné et al., 2010). By contrast, some P. freudenreichii strains that possess an extracellular polysaccharide capsule fail to immunomodulate, while mutagenetic suppression of this capsule confers immunomodulatory activity (Deutsch et al., 2012). Surface proteins of P. freudenreichii ITG P20 [Centre International de Ressources Microbiennes-Bactéries d’Intérêt Alimentaire (CIRM-BIA) 129], which is used as a cheese ripening starter (Richoux et al., 1998; Thierry et al., 2004), were investigated by a combination of proteomic methods previously developed for bacteria and eukaryotic cells (Lortal et al., 1993; Mayrhofer et al., 2006; Rodríguez-Ortega et al., 2006; Berlec et al., 2011; Bøhle et al., 2011; Bensi et al., 2012; Ythier et al., 2012; Michaux et al., 2013). This investigation demonstrated the involvement of certain S-layer proteins in immunomodulation (Bryson et al., 2006; Le Maréchal et al., 2015). Surface proteins, susceptible to enzymatic shaving and to guanidine extraction, were shown to be involved in the ability of P. freudenreichii to modulate the release of cytokines by human immune cells (Le Maréchal et al., 2015). However, the respective role of the different bacterial S-layer proteins was not fully elucidate. Immunomodulation is favored by the ability of specific strains to adhere to the host cells and mucus (Tuomola et al., 1999; Ouwehand et al., 2000; Huang and Adams, 2003; Thiel et al., 2004; Le Maréchal et al., 2015). Indeed, the local action of metabolites and of immunomodulatory molecules is favored by the ability of probiotics to adhere to the host cells. Dairy propionibacteria were shown to adhere to mice intestinal epithelial cells both ex vivo and in vivo (Zarate, 2012) as well as to cultured human intestinal cell lines in vitro (Huang and Adams, 2003; Moussavi and Adams, 2010). However, the precise mechanisms are poorly characterized in P. freudenreichii. Adhesion moreover constitutes a key criterion in strain selection and is described as the initial step for colonization of the host (Havenaar et al., 1992, havenar; Riedel et al., 2006; Preising et al., 2010), depending on crucial surface compounds, including surface proteins (Lebeer et al., 2010). The identification of adhesion mechanisms and molecules is a fundamental step in the elucidation of the bacterium/host cross-talk (van de Guchte et al., 2012). This was lacking in probiotic dairy propionibacteria. The aim of our study was thus to identify P. freudenreichii protein(s) involved in adhesion to human intestinal epithelial cells.

Materials and Methods

Bacterial Strains and Culture Conditions

The P. freudenreichii wild-type (WT) strains, genetically modified strain and plasmids used in this study are listed in Table . All strains in this study were obtained from the collection of the CIRM-BIA (STLO, INRA Rennes, France). All P. freuderenichii WT strains were grown at 30°C in YEL broth (Malik et al., 1968) without agitation or in cow’s milk ultrafiltrate supplemented with 50 mM of sodium L-lactate (galaflowSL60, Société Arnaud, Paris, France) and 5 g/L of casein hydrolysate (Organotechnie, La Courneuve, France), sterilized by 0.2 μm filtration (Nalgene, Roskilde, Denmark) as described previously (Cousin et al., 2012a). For genetically modified strains, YEL and Milk Ultrafiltrate culture media were supplemented with chloramphenicol (10 μg ml-1). The growth of P. freudenreichii strains was monitored spectrophotometrically by measuring the optical density at 650 nm (OD650), as well as by counting colony-forming units (CFUs) in YEL medium (Malik et al., 1968) containing 1.5% agar. P. freudenreichii strains was harvested in a stationary phase (76 h, 109 CFU/mL, determined by plate counts) by centrifugation (6,000 × g, 10 min, 4°C). Escherichia coli strain DH5α was grown in Luria–Bertani medium at 37°C, and cells carrying DNA plasmid were selected by addition of ampicillin (100 μg ml-1). Propionibacterium freudenreichii wild-type strains, their genetically modified derivatives and plasmids used in the study.

Enzymatic Shaving of Surface Proteins

One hundred microliter of propionibacteria stationary phase culture (see above) were harvested by centrifugation (6,000 × g, 10 min, 4°C) and washed in an equal volume of PBS [pH 8.5] containing 5 mM DTT before resuspension in 1/10 volume of the same buffer. Sequencing grade modified trypsin (V5111, Promega, Madison, WI, United States) was dissolved in the same buffer (qsp 0.2 g/L) and added to the bacterial suspension. “Shaving” was performed for 1 h at 37°C in a 0.5 mL reaction volume containing 5 × 109 bacteria and 4 μg of trypsin, with gentle agitation (180 rpm). Bacteria were removed by centrifugation (8,000 × g, 10 min, 20°C) and subjected to three washes in PBS prior to adhesion assay.

Cell Line and Culture Conditions

The human colon adenocarcinoma cell line HT-29 was obtained from ATCC (American Type Culture Collection, Rockville, MD, United States). These cells was cultured under conditions of 37°C, 5% CO2, and 90% relative humidity in DMEM High Glucose with L-Glutamine with Sodium Pyruvate (PAN, Dominique Dutscher, Brumath, France) supplemented with 10% heat-inactivated fetal calf serum (FCS) (PAN, Dominique Dutscher, Brumath, France) and antibiotics or not (for adhesion assays).

Electroporation and Inactivation of the slpB Gene in P. freudenrenichii CIRM-BIA 129 by Suicide Vector

Inactivation of P. freudenreichii gene was adapted from Deutsch et al. (2012) with some modifications. For insertional inactivation of a slpB gene, a 520-bp DNA fragment homologous to nucleotides 30–550 of the 5′ region of the slpB coding region in P. freudenreichii CIRM-BIA 129 genome was synthesized by Genscript Inc.[1] with restriction sites XbaI-slpB-5′ and BamHI-slpB-3′ resulting in pUC:ΔslpB plasmid. The pUC:ΔslpB plasmidic DNA was digested with XbaI and BamHI, purified, and cloned in plasmid pUC:CmR digested by the same enzymes, which resulted in the suicide vector pUC:ΔslpB:CmR, which was confirmed by sequencing. See Supplementary Figure . Electrocompetent P. freudenreichii CIRM-BIA 129 cells was prepared as previously described (Deutsch et al., 2012) with slight modifications. They were cultured in YEL medium supplemented with 0.5 M sucrose and 2% glycine until the early exponential growth phase (OD = 0.1), harvested (6,000 × g, 10 min, 4°C). The pellet was washed extensively in ice-cold 0.5 M sucrose and resuspended in electroporation buffer containing 0.5 M sucrose with 10% glycerol and 1 mM potassium acetate (pH 5.5). For electroporation, a 100-μl aliquot of the electrocompetent cells was mixed with 3 μg of pUC:ΔslpB:CmR plasmid DNA in a cooled electroporation cuvette. The electroporation of P. freudenreichii CIRM-BIA 129 was performed with a Gene Pulser XcellTM (Bio-Rad Laboratories, Richmond, CA, United States) at 20 kV/cm, 200-Ω resistance, and 25-μF capacitance. Immediately after the pulse, 900 μL of YEL containing 0.5 M sucrose, 20 mM MgCl2, and 2 mM CaCl2 were added before incubation, 24 H at 30°C under microaerophilic conditions. Cells were plated, and incubated 7 days at 30°C under anaerobic conditions, on YEL medium containing 1.5% agar (YELA) supplemented with 10 μg⋅ml-1 of chloramphenicol in order to select P. freudenreichii mutants harboring inserted pUC:ΔslpB:CmR. The P. freudenreichii CIRM-BIA 129 ΔslpB (CB129ΔslpB) mutant strain was further checked by proteomics for the absence of intact SlpB surface proteins as indicated in the “Results” section. Moreover, the stability of the insertion was checked after three independent cultures in YEL and Milk Ultrafiltrate media without chloramphenicol.

In Vitro Adhesion Assays

Adhesion of P. freudenreichii (WT and mutant) to the human colon adenocarcinoma cell line HT-29 was examined by adding 108 live propionibacteria (washed twice in PBS, numerated by CFU conting, ratio 100 bacteria:1 HT-29 cell, MOI 100) to 106 cells in DMEM culture medium without antibiotics. Adhesion assay was conducted by incubation of bacteria/cell at 37°C for 60 min under conditions, 5% CO2 and 90% relative humidity. Cells were washed twice with prewarmed PBS pH 7.4, and the subsequently supernatant was removed, and 400 μL of trypsin-EDTA (Invitrogen) was added to each well, before incubation for 5 min at 37°C and to trypsin inactivation by adding 800 μL of DMEM culture medium without antibiotics. Cells were harvested (3,000 × g, 3 min) and lysed in 0.1% Triton X-100 before serial dilutions and plating on YELA. Finally, plates were incubated at 30°C for 5 days under anaerobic conditions. A rate of adhesion was calculated as follows: (bacterial count after adhesion experiment/bacterial population added on to HT29 cells). The CIRM-BIA 129 WT strain was then used as a reference in this work, with a % adhesion of 100, and used to normalize all other adhesion rates as a percentage of CIRM-BIA 129 WT adhesion. Each adhesion assay was conducted in technical and biological triplicates. To test involvement of surface proteins in adhesion, propionibacteria were subjected (or not) to enzymatic shaving (see section “Enzymatic Shaving of Surface Proteins”) before adhesion assay. To confirm this hypothesis, propionibacteria were incubated 60 min at 37°C with 50 μg of P. freudenreichii CIRM-BIA 129 guanidine-extracted S-layer associated proteins, in solution in PBS, under agitation, before adhesion. This amount (50 μg) was determined after preliminary experiments to determine amounts efficient in restoring adhesion. For specific inhibition of adhesion by antibodies directed against SlpB, propionibacteria were incubated in PBS pH 7.4 with immunoglobulins purified from rabbit anti-SlpB serum (AGRO-BIO, France) in 1:10.000 dilution, under agitation, 60 min at 37°C. Propionibacteria were washed twice with PBS pH 7.4 before adhesion assay. The adhesion ratio of CB 129 strain alone was used as a reference to calculate the adhesion rates of different strains and treatments. Internalization of bacteria was determined as previously described (Bouchard et al., 2013) 2-h post contact following an additional 2-h incubation step with DMEM supplemented with gentamicin (100 μg/ml) to kill extracellular bacteria. Subsequently, HT-29 cells monolayers were washed three times with PBS, treated with trypsin, centrifuged for 5 min at 800 × g, and lysed in 0.01% Triton to allow the numeration of internalized propionibacteria population only.

Bacterial Cell Adhesion Observation by Microscopy

Observation of P. freudenreichii adhesion to cultured human colon epithelial cells was as described previously for lactobacilli (Tiptiri-Kourpeti et al., 2016), with modifications for propionibacteria. Briefly, propionibacteria, cultured as described above, were washed and resuspended in PBS, prior to the addition of 20 μM CFSE (carboxyfluorescein succinimidyl ester, cell trace proliferation kit for flow cytometry ref C34554 Thermo Fisher Scientific, Waltman, MA, United States), freshly prepared as a 1,000× solution in DMSO and kept in the dark. Incorporation of CFSE was allowed for 30 min at 30°C in the dark, prior to washing and resuspension of propionibacteria in YEL medium, 30°C. Hydrolysis of CFSE by intracellular esterase activity was allowed 30 min at 30°C in the dark to generate intracellular fluorescence. Fluorescence was checked on an epifluorescence microscope (BX-51, Olympus, equipped with a U-MWB2 fluorescence filter cube). HT-29 cells were cultured in Lab-Tek chamber slide (Thermo Fisher Scientific) and labeled bacteria were added to a 1/100 ratio (1 × 106 cells, 1 × 108 bacteria, in 1 mL of DMEM) before incubation, 1 h, 37°C. After two washes with PBS, the plasma membrane of cells was then labeled with the exogenous head-labeled phospholipid fluorescent probe N-(Lissamine rhodamine B sulfonyl) dioleoyl phosphatidylethanolamine (Rh-DOPE, Avanti Polar Lipids Inc., Birmingham, England) used at a concentration of 1 μg/mL in DMEM, for 10 min. Cell layer was then washed twice with PBS and slides mounted in DAPI (4,6-diamidino-2-phenylindole)-containing mounting medium (Vectashield mounting medium for fluorescence Vector ref H-1200). Cells were observed using a confocal Leica SP8 and a 63/1.4 oilHC PL APO CS objective. Images were acquired using LAS-AF (Leica, Wetzlar, Germany) software. For scanning electron microscopy, HT-29 cells were cultured in Corning® Transwell® polycarbonate membrane cell culture inserts on polycarbonate 0.4 μm pore size filtration membrane. Adhesion was conducted as described above. Membranes were then removed, washed in PBS, fixed 48 h by 2% (wt/vol) glutaraldehyde in 0.1 M sodium cacodylate buffer [pH 6.8] and rinsed in the same buffer. Samples were dehydrated with ethanol (10, 25, 50, 75, 95, and finally 100%), critical-point dried by the CO2 method and coated with gold. Cells were examined and photographed with a Philips XL 20 scanning electron microscope operating at 10 kV.

Bacterial Cell Adhesion Determination by Cytometric Analysis

Determination of P. freudenreichii adhesion to cultured human colon epithelial cells was performed as described previously for lactobacilli (Tiptiri-Kourpeti et al., 2016). Cells were cultured in DMEM as described above to confluence. CFSE-labeled bacteria were added as described above before a 1-h incubation at 37°C. Cells were trypsinized and analyzed by fluorescence cytometry using an excitation wavelength of 488 and emission at 585 nm (Accuri C6 Becton Dickinson, Le Pont-de-Claix, France). Data were collected from 50,000 cells and analysis was performed with CFlow software.

Guanidine Extraction of Surface Layer Associated Proteins Non-covalently Bound to the Cell Wall

Propionibacteria cultures in stationary phase (76-h) were collected by centrifugation (8,000 × g, 10 min, 4°C) for extraction of S-layer proteins by Guanidine Hydrochloride (GuaHCl) (Le Maréchal et al., 2015). The bacterial pellet was washed two times with an equal volume of PBS buffer pH 7.4. This pellet was resuspended in 5 M GuaHCl to a final OD650 of 20 then incubated 15 min at 50°C, and subsequently, the suspension was centrifuged (21.000 × g, 20 min, 30°C). The cells were eliminated, and the supernatant was dialyzed extensively against PBS buffer pH 7.4 (for adhesion assays) or 0.1% SDS (for SDS–PAGE analysis) for 24 h at 4°C using Slide-A-Lyer® Dialysis Cassette (ThermoScientific, Rockford, IL, United States). This procedure was applied in three independent cultures.

One-Dimensional SDS–Polyacrylamide Gel Electrophoresis (1-DE) and Western Blotting

Extracts of S-layer proteins in 0.1% SDS were diluted in SDS sample buffer and then heat-denatured 10 min at 95°C. One-dimensional polyacrylamide gel electrophoresis (10.0%) was conducted according to Laemmli (Laemmli, 1970) on a Mini-PROTEAN® Tetra Cell (Bio-Rad, Hercules, CA, United States) and the gels were stained using Coomassie Blue Bio-Safe reagent (Bio-Rad). Alternatively, S-layer protein associated extracts were separated by 10% SDS–PAGE and transferred to PVDF membranes (GE Healthcare). After blocking with 3% non-fat dry milk diluted in TBS (Tris 10 mM, NaCl 0.15 M, 0.3% tween 20), the membranes were incubated overnight at 4°C with primary antibodies purified from rabbit sera (AGRO-BIO, France). These were obtained by injecting the following slpB peptide to rabbits: IDATVDKQNSKGGFGWGG and used at the dilution 1:10,000. After washing, membranes were incubated with secondary antibodies: anti-rabbit IgG conjugated with horseradish peroxidase (1:15,000, AGRO-BIO, France) for 2 h at room temperature. Bound antibodies were visualized with ECL Plus system (GE Healthcare, Vélizy, France) and blots were scanned using the Syngene GBox (Ozyme, Saint-Quentin-en-Yvelines, France). The specificity of anti-SlpB western blotting was checked (Supplementary Figure ). A single band was observed only in strains expressing SlpB and the labeling pattern was distinct from that of anti-SlpA and anti-SlpE western blotting.

Data Analysis

All the experiments were performed with three technical replicates and three biological replicates, and the results were expressed as means ± standard deviations (SD). Statistical analyses were performed in R Statistical Software (Foundation for Statistical Computing, Vienna, Austria) using ANOVA with Tukey post hoc analyses for multiple comparisons.

Results

Surface Layer Associated Proteins and Adhesion to Cultured Human Colon Cells Are Variable among Strainsof P. freudenreichii

Seven strains of P. freudenreichii from the CIRM-BIA collection (Table ), CB 118, CB 121, CB 129, CB 134, CB 136, CB 508, and CB 527, have been selected based on preliminary proteomic screening as they all displayed different surface proteomes as shown by their S-layer associated protein pattern after guanidine treatment (Figure ). The five proteins, previously identified in CB 129 (SlpA, SlpB, SlpE, InlA, and LspA, see Le Maréchal et al., 2015), and thought to play a role in interactions with the host, are indicated in the figure. Preliminary results pointed out SlpB as a potential key surface protein in P. freudenreichii. We thus developped antibodies in order to confirm this. Western blot analysis using these antibodies further confirmed variability of surface proteins (Figure ). SlpB was detected in four strains out of seven, with different intensities. The variability of S-layer associated proteins suggested possible variations regarding interactions with host cells. The seven strains were further compared with respect to adhesion to HT-29 cultured colon cells (Figure ). The CB129 strain, exhibited the highest adhesion rate (6.44 CFU/1 HT-29 cell) and was used as the reference (100% adhesion) for comparison with the other strains (100.0% ± 17). Indeed, CB129 showed a significant difference (p < 0.001) with the other P. freudenreichii strains tested under the same experimental conditions. The CB118 strain exhibited a lower but significant adherence percentage of 56.0% ± 10.0 and also displayed SlpB. All the other strains exhibited low adhesion rates without significant differences among them, although CB136 (30.0% ± 5.0), which also displays SlpB, tended to be more adhesive than the rest of this subset. Finally, the lowest adhesion rate was recorded for CB527, 10.0% ± 1.0, for which no surface protein was detected, in accordance with (Deutsch et al., 2017). Different propionibacteria: HT-29-cells ratios were tested for adhesion (100:1, 500:1, and 1,000:1, in technical and biological triplicates) with similar results in adhesion rates ranking. At the MOI of 100:1 used in this study, no internalization of P. freudenreichii was observed (data not shown) using the gentamicin method used by our team to monitor staphylococci internalization (Bouchard et al., 2013). Variability of surface proteome and of adhesion among strains of Propionibacterium freudenreichii. (A) Guanidine-extracted surface layer associated proteins are variable. Seven strains of P. freudenreichii were cultured in milk ultrafiltrate and subjected to guanidine-extraction followed by SDS–PAGE (10%) gel electrophoretic analysis of the extracts. Gels were either Coomassie-Blue-stained (A) or transferred to a PVDF membrane. Surface proteins previously identified by mass spectrometry as InlA, LspA, SlpE, SlpA and SlpB in strain CB129 are indicated by 1, 2, 3, 4, and 5, respectively. (B) Western Blotting detection of surface layer protein SlpB. PVDF membranes were treated using rabbit antibodies raised against P. freudenreichii surface layer protein SlpB. (C) Adhesion to cultured human colon epithelial cells is variable. HT-29 cells were cultured to confluence in DMEM prior to co-incubation. Each well (1 × 106 HT-29 cells) was added with 1 × 108 colony-forming unit (CFU) of P. freudenreichii. Co-incubation was 60 min at 37°C in DMEM. After thorough washing with PBS, adhered bacteria were enumerated by CFU plate counting in trypsinized cells. Numbers of the strains used are indicated. Asterisks represent statistically significant differences between strains and were indicated as follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Adhesion is presented as a percent of the reference CB129 P. freudenreichii strain. Original gels and western blots, uncropped, are provided in Supplementary Figure .

P. freudenreichii CB129 Interacts with Cultured Human Colon Cells

Adhesion of P. freudenreichii to HT-29 cells being demonstrated, we further looked at such an interaction, using three-dimensional confocal microscopy. As seen in Figure , the sections close to the bottom of the slide culture chamber mainly exhibited the blue fluorescence of the HT-29 nuclei, stained with DAPI, a poorly fluorescent cytoplasm, surrounded by a red-stained plasma membrane (lowest images in Figure ). Ascending within this “z-stack,” higher sections showed dots with intense red fluorescence, corresponding to cell membranes, indicative of colonocytes microvilli constituting the brush border. Higher sections showed co-localization of these red dots with green-fluorescent propionibacteria, caused by CFSE metabolization within propionibacteria. More precisely, propionibacteria appeared as aggregates, in the intercellular space of the epithelial HT-29 monolayer. This localization of propionibacteria in contact with cells is further illustrated in the reconstituted 3-D view (Figure ). Interaction of propionibacteria with cultured human colonocytes was further illustrated by scanning electron microscopy of co-cultures on cell culture inserts (Figure ). This revealed localization of propionibacteria at the surface of cells, in contact with the brush border. Microscopy imaging of P. freudenreichii Centre International de Ressources Microbiennes–Bactéries d’Intérêt Alimentaire (CIRM-BIA) 129 adhesion to cultured human colon epithelial cells. HT-29 cells were cultured to confluence in DMEM on a slide chamber prior to interaction. P. freudenreichii was cultured in fermented milk ultrafiltrate prior to intracellular labeling of live bacteria using CFSE. Labeled bacteria were then co-incubated with colon cells in a slide chamber prior to washing with PBS and to staining of plasma membrane using Rh-DOPE and mounting in DAPI-containing mounting medium. (A,B) Blue fluorescence evidences colon cells nuclei, red fluorescence their plasma membrane and green fluorescence CFSE-labeled propionibacteria. (A) Z-stack, i.e., confocal images acquired at different “z” altitudes in the labeled preparation. (B) Reconstituted 3-D image showing a cluster of propionibacteria at surface of cells. (C) Scanning electron microscopy observation of propionibacteria adhesion to cultured colon epithelial cells. The same co-incubation was performed in a polycarbonate membrane cell culture insert prior to fixation and scanning electron microscopy observation.

P. freudenreichii CB129 Adhesion to Cultured Human Colon Cells Involves Surface Proteins

To determine whether the presence of surface proteins is involved in the adhesion of P. freudenreichii to HT-29 cells, the method of enzymatic shaving using trypsin was applied, before adhesion assay. A significant reduction (p < 0.001) was observed in the adhesion rate: 21.77 ± 8.10% for shaved bacteria, compared to the positive control consisting of propionibacteria (Figure ). Western blot analysis also indicated absence of SlpB at the surface of P. freudenreichii as a result of shaving (Figure ). To further confirm the role of surface proteins in adhesion, P. freudenreichii CB129 cells, shaved or not, were incubated with 50 μg of extracted surface proteins. This guanidine extract from the CB129 strain was previously dialyzed against PBS and quantified by Bradford assay. It contained the five proteins (SlpA, SlpB, SlpE, InlA, and LspA, see Figure ) in PBS buffer pH 7.4. Adhesion assay was then conducted. This incubation increased the rate of adhesion of P. freudenreichii CB129 to HT-29 cells, from 100.00% ± 8.93 to 317.07% ± 46.68. Furthermore, adhesion rate, which was strongly diminished by enzymatic shaving (33.99% ± 14.30), was restored by this incubation (157.44% ± 18.31, Figure ). This further experiment confirmed the key role of at least one of these surface proteins in adhesion. Involvement of P. freudenreichii surface proteins in adhesion. (A) Trypsin shaving reduces P. freudenreichii CIRM-BIA 129 adhesion. Human colon cells were cultured in DMEM prior to co-incubation with propionibacteria. Used propionibacteria were either untreated (control) or submitted to trypsin shaving of surface proteins for 60 min (trypsin). Adhered bacteria were enumerated by CFU plate counting in trypsinized cells. (B) Trypsin shaving reduces presence of SlpB protein in P. freudenreichii CIRM-BIA 129 in different times of incubation. P. freudenreichii CIRM-BIA 129 show after different incubations time with trypsin (Tzero min, T30 min, T60 min, and T120 min) a decreased amount of SlpB in Western Blot analysis with anti-SlpB antibodies. (C) Addition of extracted surface layer proteins enhances P. freudenreichii CIRM-BIA 129 adhesion. Human colon cells were cultured prior to co-incubation with propionibacteria. Used propionibacteria were either shaved for 60 min (trypsin) or untreated (control). They were then added with surface layer guanidine extract (50 μg of proteins) or not. Adhesion was quantified by plate CFU counting of propionibacteria after trypsinization of colon cells. Adhesion is presented as a percent of the reference CIRM-BIA 129 P. freudenreichii strain. Asterisks represent statistically significant differences between strains and were indicated as follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Adhesion is presented as a percent of the reference CB129 P. freudenreichii strain.

Surface Protein SlpB Plays a Key Role in Adhesion to Cultured Human Colon Cells

In a second approach to inhibit adhesion and to precise the role of specific surface proteins, P. freudenreichii was incubated with antibodies raised against SlpB, at a dilution of 1:10,000, before adhesion assay. This resulted in a significant reduction following incubation with the anti-SlpB antibodies 39.95% ± 6.92 (p < 0.001), (Figure ). We then further focused on SlpB and inactivated its gene in P. freudenreichii CB129. The mutant P. freudenreichii CB129ΔslpB was obtained by insertion of the pUC:ΔslpB:CmR suicide plasmid as described in the “Materials and Methods” section (Supplementary Figure ). The stability of the mutant was validated after growth in the presence or absence of chloramphenicol by checking for the absence of SlpB production. As shown in Figure , one protein band (about 55 kDa in size) was lacking in the mutant S-layer associated proteins guanidine extract (line 2), when compared to the WT parental strain (line 1). Western Blot analysis using antibodies raised against the SlpB protein (Figure ) confirmed that this protein was effectively mutated in the mutant (line 2) when compared to the parental strain (line 1). Efficient and specific inactivation of the slpB gene was further established by mass spectrometry analysis of guanidine-extracted S-layer proteins. Indeed, the SlpA, SlpB, and SlpE proteins were clearly identified in the WT CB129 strains, while only SlpA and SlpE were detected in the mutant P. freudenreichii CB129ΔslpB strain (Table ). Key role of surface layer protein SlpB in adhesion. (A) Antibodies reduce P. freudenreichii adhesion and so does slpB gene inactivation. Human colon cells were cultured in DMEM prior to co-incubation with propionibacteria. P. freudenreichii CIRM-BIA 129 was treated with antibodies raised against SlpB prior to adhesion assay. As an alternative, the slpB gene was inactivated in P. freudenreichii CIRM-BIA 129 prior to adhesion assay. Adhesion is presented as a percent of the reference CB129 P. freudenreichii strain. (B) Guanidine-extracted surface layer associated proteins were compared by SDS–PAGE in P. freudenreichii CIRM-BIA 129 wild-type (line 1) and in the corresponding mutant CB129ΔslpB (line 2). (C) The corresponding PVDF membrane was subjected to Western Blotting using rabbit antibodies raised against P. freudenreichii surface layer protein SlpB (B). (D,E) Fluorescently labeled live P. freudenreichii CIRM-BIA 129 adheres to cultured human colon epithelial HT-29 cells. The adhesion of CFSE-labeled propionibacteria was detected by the shift in FL1 intensity (E), compared to HT-29 cells with unlabelled propionibacteria (D). Cells (106) were co-incubated with 108 CFU of CFSE-stained propionibacteria for 1 h. At least 50.000 cells per sample were analyzed. As an alternative, labeled P. freudenreichii mutant CB129ΔslpB was co-incubated with HT-29 cells (F). Original gels and western blots, uncropped, are provided in Supplementary Figure . Asterisks represent statistically significant differences between strains and were indicated as follows: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Adhesion is presented as a percent of the reference CB129 P. freudenreichii strain. Surface-layer proteins identified after Guanidine Hydrochloride extraction. Adhesion to HT-29 cells was then assessed by CFU counting and the mutant CB129ΔslpB strain was impaired in adhesion (20.66% ± 8.32) when compared to the WT control (100.00% ± 7.37) (Figure , p < 0.001). To confirm this result, adhesion of P. freudenreichii to HT-29 cells, using CFSE-stained propionibacteria, was quantified by flow cytometry. Cells were treated with CFSE-labeled propionibacteria, WT or CB129ΔslpB mutant, for 1 h, before cytometric monitoring of cell fluorescence (Figures ). A shift in fluorescence intensity (FL1) was observed as a result of fluorescent P. freudenreichii CB129 adhesion to cells (Figure ) when compared with control cells without bacteria (Figure ). This indicates an increase of fluorescence emission at 488 nm, corresponding to 6-carboxyfluorescein succinimidyl harbored by adhering bacteria, as described previously for lactobacilli (Tiptiri-Kourpeti et al., 2016). By contrast, the mutant CB129ΔslpB strain failed to reproduce this fluorescence shift in HT-29 cells, and the pattern (Figure ) was similar to that of HT-29 without bacteria (Figure ). Altogether, these results confirm the key role of the SlpB surface protein in adhesion of P. freudenreichii to HT-29 cells.

Discussion

Adhesion is a key determinant of host/bacterium interactions, whether pathogenic or probiotic. Adhesion of probiotic bacteria to host intestinal cells may favor important effects including modulation of mucus secretion (Mack et al., 2003), of defensin production (Schlee et al., 2007, 2008), or the local action of beneficial metabolites. It can improve competitive exclusion of pathogens by adhesion competition (Servin, 2004; Lebeer et al., 2008) and constitutes a key factor for several clinical applications of probiotics in the prevention and treatment of gastrointestinal disorders and of IBD. It may involve, on the bacterial side, various microorganism-associated molecular patterns (MAMPs) including flagellin, fimbriae (also called pili) or other surface proteins including moonlighting proteins and S-layer proteins (Lebeer et al., 2010). Surface-layer proteins constitute a field of research that deserves further investigation. Although anchored to the cell wall via conserved SLH domains, their extracellular protruding part is highly variable, poorly conserved amongst bacterial species and strains. A previous paradigm described S-layers as a macromolecular paracrystalline network formed by the self-assembly of numerous copies of one monomeric protein or glycoprotein and constituting an extracellular S-layer in many bacteria (Sleytr, 1997; Sára and Sleytr, 2000). This was later challenged by studies on Lactobacillus acidophilus showing that a S-layer can contain various S-layer proteins or SLPs (Hymes et al., 2016). These proteins are in fact versatile molecules that may play an important role in growth and survival, maintenance of cell integrity, enzyme display, molecular sieving, co-aggregation, immunomodulation, as well as adhesion and persistence within the animal host (Lebeer et al., 2010; Fagan and Fairweather, 2014). In P. freudenreichii, such proteins were shown to be involved in immunomodulatory interactions with the host (Le Maréchal et al., 2015), a property highly strain-dependent (Mitsuyama et al., 2007; Foligné et al., 2010, 2013). Indeed, a functional role in immunomodulation by P. freudenreichii was recently attributed to a set of proteins: SlpB, SlpE, two putative S-layer proteins with SLH domains, and HsdM3, predicted as cytoplasmic (Deutsch et al., 2017). Variability of P. freudenreichii surface proteins may thus be related to variability in functional properties. In this context, we have selected in the present work seven P. freudenreichii strains with different patterns evidenced in a preliminary study. We confirm here that P. freudenreichii S-layer proteins are variable, and so is its ability to adhere to cultured human epithelial cells, as determined by quantitative culturing (Mack et al., 1999), which suggests a functional link between variations in the surface protein pattern. P. freudenreichii CIRM-BIA 129, shown to alleviate symptoms of acute colitis in mice, displays S-layer associated proteins and the highest adhesion ability, whatever the bacteria/cell ratio (100:1; 500:1; and 1,000:1). Moreover, at a ratio of 100/1, no internalization was observed. This suggests that propionibacteria either do not internalize into cultured HT-29 cells, or do not suvive within the cells. Cultured colon epithelial HT-29 cells do not produce mucus in our conditions. This suggests that P. freudenreichii interacts with epithelial cell surface compounds rather than mucins, a property previously reported for the probiotic L. acidophilus (Johnson et al., 2013). Interestingly, CB129 was shown to restore expression of ZO-1, a key protein of tight junctions which expression was impaired in colitis (Plé et al., 2015), as part of its anti-inflammatory effect. Adhesion close to these junctions may favor the local action of propionibacteria via local release of propionate, the major metabolite of propionibacteria, which was shown to improve intestinal barrier function and to restore expression of ZO-1 in DSS-treated mice (Tong et al., 2016). Accordingly, protection toward inflammation-induced barrier defects was reported for the probiotic product VSL#3 (Krishnan et al., 2016). Enzymatic shaving of surface proteins reduced adhesion and was previously shown to hydrolyze at least 16 distinct proteins (Le Maréchal et al., 2015). Dramatic inhibition of adhesion was observed following blockage with antibodies raised against SlpB. Interruption of the slpB gene in CB129 strain also resulted in a drastic reduction (P < 0.01) in adhesion. Moreover, addition of purified S-layer proteins restored the adhesion that was suppressed in P. freudenreichii by enzymatic shaving. Altogether, these results indicate a role of P. freudenreichii S-layer protein, including SlpB, in adhesion, as was reported for the SlpA protein in L. acidophilus NCFM (Buck et al., 2005). This study evidenced a key role of one of the P. freudenreichii S-layer proteins in adhesion to human intestinal cells. Understanding determinants of probiotic action is a key challenge. It opens new avenues for the screening of most promising propionibacteria strains, by monitoring their expression, and for the development of new functional products containing them. It is particularly relevant in the context of pathogens competitive exclusion and inflammation remediation.

Author Contributions

GJ and FdC designed the research. GJ, YL, and VA supervised the work. FdC, HR, SH, FG, MD, SD, and JJ took part to the experiments. FdC and GJ wrote the manuscript. YL and VA corrected the manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Table 1

Propionibacterium freudenreichii wild-type strains, their genetically modified derivatives and plasmids used in the study.

Strains and plasmidsRelevant genotype and phenotypeSource or reference
Strains P. freudenreichiia
CB 118Wild-type; SlpA, SlpB, SlpE, and InlA proteins detected in guanidine extractbCIRM-BIA
CB 121Wild-type; InlA and LspA proteins detected in guanidine extractCIRM-BIA
CB 129Wild-type; SlpA, SlpB, SlpE, InlA, and LspA proteins detected in guanidine extractCIRM-BIA
CB 134Wild-type; SlpA, SlpE, InlA, and LspA proteins detected in guanidine extractCIRM-BIA
CB 136Wild-type; SlpA, SlpB, InlA, and LspA proteins detected in guanidine extractCIRM-BIA
CB 508Wild-type; SlpA, SlpB, SlpE, InlA, and LspA proteins detected in guanidine extractCIRM-BIA
CB 527Wild-type; Absence of surface layer proteins in guanidine extractCIRM-BIA
CB 129ΔslpBCmr; CIRM-BIA 129 with chromosomal insertion of pUC:ΔslpB:CmR in the slpB sequence; SlpB protein absent in guanidine extractThis Study
Plasmids
pUC:slpBpUC18; Amp; harboring slpB partial gene sequence for inactivationThis Study
pUC:ΔslpB:CmRpUC18 carrying a chloramphenicol resistance gene and harboring slpB partial gene sequenceThis Study
Table 2

Surface-layer proteins identified after Guanidine Hydrochloride extraction.

Wild-type strain
Delta SlpB strain
Gene nameLocus tagLog (e-value)aCover (%)bPeptidescLog (e-value)aCover (%)bPeptidesc
SlpBPFCIRM129_00700-263.27434000
SlpEPFCIRM129_05460-125.65019-138.85518
SlpAPFCIRM129_09350-174.37524-143.56822
  50 in total

1.  Identification of candidate carrier proteins for surface display on Lactococcus lactis by theoretical and experimental analyses of the surface proteome.

Authors:  Aleš Berlec; Petra Zadravec; Zala Jevnikar; Borut Štrukelj
Journal:  Appl Environ Microbiol       Date:  2010-12-23       Impact factor: 4.792

2.  Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria.

Authors:  G Jan; A-S Belzacq; D Haouzi; A Rouault; D Métivier; G Kroemer; C Brenner
Journal:  Cell Death Differ       Date:  2002-02       Impact factor: 15.828

Review 3.  Probiotics, prebiotics and the gastrointestinal tract in health and disease.

Authors:  Luis Vitetta; David Briskey; Hollie Alford; Sean Hall; Samantha Coulson
Journal:  Inflammopharmacology       Date:  2014-03-16       Impact factor: 4.473

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens.

Authors:  Sarah Lebeer; Jos Vanderleyden; Sigrid C J De Keersmaecker
Journal:  Nat Rev Microbiol       Date:  2010-03       Impact factor: 60.633

6.  An in vitro model for investigating intestinal adhesion of potential dairy propionibacteria probiotic strains using cell line C2BBe1.

Authors:  Y Huang; M C Adams
Journal:  Lett Appl Microbiol       Date:  2003       Impact factor: 2.858

7.  VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier Defects.

Authors:  Moorthy Krishnan; Harrison M Penrose; Nilay N Shah; Ronald R Marchelletta; Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2016-12       Impact factor: 5.325

8.  Inhibition of Staphylococcus aureus invasion into bovine mammary epithelial cells by contact with live Lactobacillus casei.

Authors:  Damien S Bouchard; Lucie Rault; Nadia Berkova; Yves Le Loir; Sergine Even
Journal:  Appl Environ Microbiol       Date:  2012-11-26       Impact factor: 4.792

9.  Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case.

Authors:  Giuliano Bensi; Marirosa Mora; Giovanna Tuscano; Massimiliano Biagini; Emiliano Chiarot; Mauro Bombaci; Sabrina Capo; Fabiana Falugi; Andrea G O Manetti; Paolo Donato; Erwin Swennen; Marilena Gallotta; Manuela Garibaldi; Vittoria Pinto; Nico Chiappini; James M Musser; Robert Janulczyk; Massimo Mariani; Maria Scarselli; John L Telford; Renata Grifantini; Nathalie Norais; Immaculada Margarit; Guido Grandi
Journal:  Mol Cell Proteomics       Date:  2012-01-27       Impact factor: 5.911

10.  Identification of proteins involved in the anti-inflammatory properties of Propionibacterium freudenreichii by means of a multi-strain study.

Authors:  Stéphanie-Marie Deutsch; Mahendra Mariadassou; Pierre Nicolas; Sandrine Parayre; Rozenn Le Guellec; Victoria Chuat; Vincent Peton; Caroline Le Maréchal; Julien Burati; Valentin Loux; Valérie Briard-Bion; Julien Jardin; Coline Plé; Benoît Foligné; Gwénaël Jan; Hélène Falentin
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

View more
  18 in total

Review 1.  Extractable Bacterial Surface Proteins in Probiotic-Host Interaction.

Authors:  Fillipe L R do Carmo; Houem Rabah; Rodrigo D De Oliveira Carvalho; Floriane Gaucher; Barbara F Cordeiro; Sara H da Silva; Yves Le Loir; Vasco Azevedo; Gwénaël Jan
Journal:  Front Microbiol       Date:  2018-04-04       Impact factor: 5.640

2.  The Cheese Matrix Modulates the Immunomodulatory Properties of Propionibacterium freudenreichii CIRM-BIA 129 in Healthy Piglets.

Authors:  Houem Rabah; Stéphanie Ferret-Bernard; Song Huang; Laurence Le Normand; Fabien J Cousin; Floriane Gaucher; Romain Jeantet; Gaëlle Boudry; Gwénaël Jan
Journal:  Front Microbiol       Date:  2018-10-29       Impact factor: 5.640

Review 3.  Dietary Nutrients, Proteomes, and Adhesion of Probiotic Lactobacilli to Mucin and Host Epithelial Cells.

Authors:  Hasan Ufuk Celebioglu; Birte Svensson
Journal:  Microorganisms       Date:  2018-08-21

4.  Mutation of the Surface Layer Protein SlpB Has Pleiotropic Effects in the Probiotic Propionibacterium freudenreichii CIRM-BIA 129.

Authors:  Fillipe L R do Carmo; Wanderson M Silva; Guilherme C Tavares; Izabela C Ibraim; Barbara F Cordeiro; Emiliano R Oliveira; Houem Rabah; Chantal Cauty; Sara H da Silva; Marcus V Canário Viana; Ana C B Caetano; Roselane G Dos Santos; Rodrigo D de Oliveira Carvalho; Julien Jardin; Felipe L Pereira; Edson L Folador; Yves Le Loir; Henrique C P Figueiredo; Gwénaël Jan; Vasco Azevedo
Journal:  Front Microbiol       Date:  2018-08-17       Impact factor: 5.640

Review 5.  Proteomics for the Investigation of Surface-Exposed Proteins in Probiotics.

Authors:  Rosa Anna Siciliano; Rosa Lippolis; Maria Fiorella Mazzeo
Journal:  Front Nutr       Date:  2019-04-24

6.  Probiotic Propionibacterium freudenreichii requires SlpB protein to mitigate mucositis induced by chemotherapy.

Authors:  Fillipe Luiz Rosa do Carmo; Houem Rabah; Barbara Fernandes Cordeiro; Sara Heloisa da Silva; Rafaela Miranda Pessoa; Simone Odília Antunes Fernandes; Valbert Nascimento Cardoso; Valérie Gagnaire; Martine Deplanche; Bruna Savassi; Alessandra Figueiroa; Emiliano Rosa Oliveira; Caio César Fonseca; Maria Izabel Alves Queiroz; Núbia Morais Rodrigues; Sávio Henrique de Cicco Sandes; Álvaro Cantini Nunes; Luisa Lemos; Juliana de Lima Alves; Ana Maria Caetano Faria; Ênio Ferreira; Yves Le Loir; Gwénaël Jan; Vasco Azevedo
Journal:  Oncotarget       Date:  2019-12-31

7.  Regulating colonic dendritic cells by commensal glycosylated large surface layer protein A to sustain gut homeostasis against pathogenic inflammation.

Authors:  Yong Ge; Minghao Gong; Mojgan Zadeh; Jing Li; Jeffrey R Abbott; Wei Li; Laurence Morel; Roberto Sonon; Nitin T Supekar; Parastoo Azadi; Yating Wang; Dean P Jones; Shuzhao Li; Mansour Mohamadzadeh
Journal:  Mucosal Immunol       Date:  2019-10-16       Impact factor: 7.313

8.  Secretome profiling of Propionibacterium freudenreichii reveals highly variable responses even among the closely related strains.

Authors:  Esther Frohnmeyer; Paulina Deptula; Tuula A Nyman; Pia K S Laine; Helena Vihinen; Lars Paulin; Petri Auvinen; Eija Jokitalo; Vieno Piironen; Pekka Varmanen; Kirsi Savijoki
Journal:  Microb Biotechnol       Date:  2018-02-28       Impact factor: 5.813

9.  Extracellular Vesicles Produced by the Probiotic Propionibacterium freudenreichii CIRM-BIA 129 Mitigate Inflammation by Modulating the NF-κB Pathway.

Authors:  Vinícius de Rezende Rodovalho; Brenda Silva Rosa da Luz; Houem Rabah; Fillipe Luiz Rosa do Carmo; Edson Luiz Folador; Aurélie Nicolas; Julien Jardin; Valérie Briard-Bion; Hervé Blottière; Nicolas Lapaque; Gwenaël Jan; Yves Le Loir; Vasco Ariston de Carvalho Azevedo; Eric Guédon
Journal:  Front Microbiol       Date:  2020-07-07       Impact factor: 5.640

10.  Dairy Propionibacterium freudenreichii ameliorates acute colitis by stimulating MUC2 expression in intestinal goblet cell in a DSS-induced colitis rat model.

Authors:  Seongho Ma; Jiah Yeom; Young-Hee Lim
Journal:  Sci Rep       Date:  2020-03-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.